Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 1
1960 1
1961 1
1962 2
1963 14
1964 8
1965 17
1966 13
1967 9
1968 12
1969 19
1970 20
1971 13
1972 17
1973 15
1974 27
1975 13
1976 25
1977 25
1978 30
1979 21
1980 31
1981 41
1982 46
1983 49
1984 61
1985 41
1986 65
1987 62
1988 69
1989 74
1990 62
1991 69
1992 57
1993 75
1994 80
1995 71
1996 98
1997 88
1998 91
1999 77
2000 89
2001 104
2002 125
2003 114
2004 104
2005 156
2006 124
2007 137
2008 148
2009 140
2010 157
2011 191
2012 197
2013 200
2014 217
2015 222
2016 220
2017 240
2018 290
2019 278
2020 328
2021 344
2022 340
2023 300
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

5,821 results

Results by year

Filters applied: . Clear all
Page 1
Adjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, ASCOT): a multicentre, open-label, randomised, controlled, phase 3 trial.
Nakachi K, Ikeda M, Konishi M, Nomura S, Katayama H, Kataoka T, Todaka A, Yanagimoto H, Morinaga S, Kobayashi S, Shimada K, Takahashi Y, Nakagohri T, Gotoh K, Kamata K, Shimizu Y, Ueno M, Ishii H, Okusaka T, Furuse J; Hepatobiliary and Pancreatic Oncology Group of the Japan Clinical Oncology Group (JCOG-HBPOG). Nakachi K, et al. Among authors: shimizu y. Lancet. 2023 Jan 21;401(10372):195-203. doi: 10.1016/S0140-6736(22)02038-4. Lancet. 2023. PMID: 36681415 Clinical Trial.
First-line pembrolizumab ± chemotherapy for recurrent/metastatic head and neck cancer: Japanese subgroup of KEYNOTE-048.
Takahashi S, Oridate N, Tanaka K, Shimizu Y, Fujimoto Y, Matsumoto K, Yokota T, Yamazaki T, Takahashi M, Ueda T, Hanai N, Yamaguchi H, Hara H, Yoshizaki T, Yasumatsu R, Nakayama M, Shiga K, Fujii T, Mitsugi K, Takahashi K, Nohata N, Gumuscu B, Swaby RF, Tahara M. Takahashi S, et al. Among authors: shimizu y. Int J Clin Oncol. 2022 Dec;27(12):1805-1817. doi: 10.1007/s10147-022-02233-6. Epub 2022 Oct 20. Int J Clin Oncol. 2022. PMID: 36264378 Free PMC article. Clinical Trial.
Discovery of ^{39}Na.
Ahn DS, Amano J, Baba H, Fukuda N, Geissel H, Inabe N, Ishikawa S, Iwasa N, Komatsubara T, Kubo T, Kusaka K, Morrissey DJ, Nakamura T, Ohtake M, Otsu H, Sakakibara T, Sato H, Sherrill BM, Shimizu Y, Sumikama T, Suzuki H, Takeda H, Tarasov OB, Ueno H, Yanagisawa Y, Yoshida K. Ahn DS, et al. Among authors: shimizu y. Phys Rev Lett. 2022 Nov 18;129(21):212502. doi: 10.1103/PhysRevLett.129.212502. Phys Rev Lett. 2022. PMID: 36461972
Visible-Light-Induced Aminochlorination of Alkenes.
Mejri E, Higashida K, Kondo Y, Nawachi A, Morimoto H, Ohshima T, Sawamura M, Shimizu Y. Mejri E, et al. Among authors: shimizu y. Org Lett. 2023 Jun 23;25(24):4581-4585. doi: 10.1021/acs.orglett.3c01645. Epub 2023 Jun 8. Org Lett. 2023. PMID: 37289073
First observation of 28O.
Kondo Y, Achouri NL, Falou HA, Atar L, Aumann T, Baba H, Boretzky K, Caesar C, Calvet D, Chae H, Chiga N, Corsi A, Delaunay F, Delbart A, Deshayes Q, Dombrádi Z, Douma CA, Ekström A, Elekes Z, Forssén C, Gašparić I, Gheller JM, Gibelin J, Gillibert A, Hagen G, Harakeh MN, Hirayama A, Hoffman CR, Holl M, Horvat A, Horváth Á, Hwang JW, Isobe T, Jiang WG, Kahlbow J, Kalantar-Nayestanaki N, Kawase S, Kim S, Kisamori K, Kobayashi T, Körper D, Koyama S, Kuti I, Lapoux V, Lindberg S, Marqués FM, Masuoka S, Mayer J, Miki K, Murakami T, Najafi M, Nakamura T, Nakano K, Nakatsuka N, Nilsson T, Obertelli A, Ogata K, de Oliveira Santos F, Orr NA, Otsu H, Otsuka T, Ozaki T, Panin V, Papenbrock T, Paschalis S, Revel A, Rossi D, Saito AT, Saito TY, Sasano M, Sato H, Satou Y, Scheit H, Schindler F, Schrock P, Shikata M, Shimizu N, Shimizu Y, Simon H, Sohler D, Sorlin O, Stuhl L, Sun ZH, Takeuchi S, Tanaka M, Thoennessen M, Törnqvist H, Togano Y, Tomai T, Tscheuschner J, Tsubota J, Tsunoda N, Uesaka T, Utsuno Y, Vernon I, Wang H, Yang Z, Yasuda M, Yoneda K, Yoshida S. Kondo Y, et al. Among authors: shimizu y. Nature. 2023 Aug;620(7976):965-970. doi: 10.1038/s41586-023-06352-6. Epub 2023 Aug 30. Nature. 2023. PMID: 37648757 Free PMC article.
Formylation Reaction of Amines Using N-Formylcarbazole.
Kang B, Shimizu Y, Tamura Y, Fukuda E, Hamamoto KI, Uchida Y, Yasuno Y, Nakayama A, Satoh T, Kuse M, Shinada T. Kang B, et al. Among authors: shimizu y. Chem Pharm Bull (Tokyo). 2022;70(7):492-497. doi: 10.1248/cpb.c22-00161. Chem Pharm Bull (Tokyo). 2022. PMID: 35786568 Free article.
5,821 results